Diabetic Neuropathy

Foot and Ankle Clinics

Volumn 11, Issue 4, 2006, Pages 753-774

  Bibbo, Christopher ^a,b   Patel, Dipak V ^c  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

CLASSIFICATION; DIABETIC NEUROPATHY; HUMAN; PANCREAS TRANSPLANTATION; PATHOLOGY; REVIEW; SENSORY DYSFUNCTION;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; DIABETIC NEUROPATHIES; HUMANS; PANCREAS TRANSPLANTATION; SENSATION DISORDERS;

EID: 33750620683     PISSN: 10837515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fcl.2006.06.011     Document Type: Review

References (83)

1. Sheehan M.T. Current therapeutic options in type 2 diabetes mellitus: a practical approach. Clin Med Res 1 3 (2003) 173-174
2. Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 8 16 Suppl (2002) S441-S449
3. Singh N., Armstrong D.G., and Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 293 2 (2005) 217-228
4. Pecoraro R.E., Reiber G.E., and Burgess E.M. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13 5 (1990) 513-521
5. Vincent A.M., Russell J.W., Low P., et al. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25 4 (2004) 612-628
6. Cameron N.E., and Cotter M.A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 45 2-3 (1999) 137-146
7. Podwall D., and Gooch C. Diabetic neuropathy: clinical features, etiology, and therapy. Curr Neurol Neurosci Rep 4 1 (2004) 55-61
8. Brewster W.J., Fernyhough P., Diemel L.T., et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 17 8 (1994) 321-325
9. Ferreira L.D., Huey P.U., Pulford B.E., et al. Sciatic nerve lipoprotein lipase is reduced in streptozotocin-induced diabetes and corrected by insulin. Endocrinology 143 4 (2002) 1213-1217
10. Hall K.E., Liu J., Sima A.A., et al. Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy. J Neurophysiol 86 2 (2001) 760-770
11. Shah B.S., Gonzalez M.I., Bramwell S., et al. Beta3, a novel auxiliary subunit for the voltage gated sodium channel is upregulated in sensory neurons following streptozocin induced diabetic neuropathy in rat. Neurosci Lett 309 1 (2001) 1-4
12. Siemionow M., and Demir Y. Diabetic neuropathy: pathogenesis and treatment. J Reconstr Microsurg 20 3 (2004) 241-252
13. Hafer-Macko C.E., Ivey F.M., Gyure K.A., et al. Thrombomodulin deficiency in human diabetic nerve microvasculature. Diabetes 51 6 (2002) 1957-1963
14. Vinik A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90 8 (2005) 4936-4945
15. Saltzman C.L., Rashid R., Hayes A., et al. 4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients. J Bone Joint Surg Am 86-A 4 (2004) 717-723
16. Spruce M.C., Potter J., and Coppini D.V. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med 20 2 (2003) 88-98
17. Dyck P.J., Kratz K.M., Karnes J.L., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43 4 (1993) 817-824
18. Rix M., Andreassen H., and Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22 5 (1999) 827-831
19. Herbst S.A., Jones K.B., and Saltzman C.L. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 86-B 3 (2004) 378-383
20. Jeffcoate W.J., Game F., and Cavanagh P.R. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366 9502 (2005) 2058-2061
21. Kon T., Cho T.J., Aizawa T., et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16 6 (2001) 1004-1014
22. Gough A., Abraha H., Li F., et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med 14 7 (1997) 527-531
23. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 14 (1993) 977-986
24. Klein R., Klein B.E., and Moss S.E. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124 1 Pt 2 (1996) 90-96
25. Nagamatsu M., Nickander K.K., Schmelzer J.D., et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18 8 (1995) 1160-1167
26. Reljanovic M., Reichel G., Rett K., et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 31 3 (1999) 171-179
27. Ametov A.S., Barinov A., Dyck P.J., et al. (SYDNEY Trial Study Group). The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26 3 (2003) 770-776
28. Ziegler D., Nowak H., Kempler P., et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21 2 (2004) 114-121
29. Hahm J.R., Kim B.J., and Kim K.W. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients. J Diabetes Complications 18 2 (2004) 79-85
30. Tankova T., Cherninkova S., and Koev D. Treatment for diabetic mononeuropathy with alpha-lipoic acid. Int J Clin Pract 59 6 (2005) 645-650
31. Collins S.L., Moore R.A., McQuay H.J., et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 20 6 (2000) 449-458
32. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6 1 (2006) 108-113
33. Adriaensen H., Plaghki L., Mathieu C., et al. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabetes Metab Res Rev 21 3 (2005) 231-240
34. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 21 (1998) 1831-1836
35. Dallocchio C., Buffa C., Mazzarello P., et al. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 20 4 (2000) 280-285
36. Gilron I., Bailey J.M., Tu D., et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 13 (2005) 1324-1334
37. Richter R.W., Portenoy R., Sharma U., et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6 4 (2005) 253-260
38. Dogra S., Beydoun S., Mazzola J., et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 9 5 (2005) 543-554
39. Rull J.A., Quibrera R., Gonzalez-Millan H., et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 5 4 (1969) 215-218
40. Chakrabarti A.K., and Samantaray S.K. Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. Aust N Z J Med 6 6 (1976) 565-568
41. Saudek C.D., Werns S., and Reidenberg M.M. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 22 2 (1977) 196-199
42. Tremont-Lukats I.W., Megeff C., and Backonja M.M. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 60 5 (2000) 1029-1052
43. Thienel U., Neto W., Schwabe S.K., et al. Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 110 4 (2004) 221-231
44. Raskin P., Donofrio P.D., Rosenthal N.R., et al. CAPSS-141 Study Group. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63 5 (2004) 865-873
45. Watson C.P., Moulin D., Watt-Watson J., et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105 1-2 (2003) 71-78
46. Gimbel J.S., Richards P., and Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 60 6 (2003) 927-934
47. Harati Y., Gooch C., Swenson M., et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50 6 (1998) 1842-1846
48. Harati Y., Gooch C., Swenson M., et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 14 2 (2000) 65-70
49. Sindrup S.H., Andersen G., Madsen C., et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 83 1 (1999) 85-90
50. Sindrup S.H., Gram L.F., Brosen K., et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 2 (1990) 135-144
51. Sindrup S.H., Grodum E., Gram L.F., et al. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study. Ther Drug Monit 13 5 (1991) 408-414
52. Goldstein D.J., Lu Y., Detke M.J., et al. Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain 116 1-2 (2005) 109-118
53. Westanmo A.D., Gayken J., and Haight R. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Am J Health Syst Pharm 62 23 (2005) 2481-2490
54. Raskin J., Pritchett Y.L., Wang F., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6 5 (2005) 346-356
55. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Arch Intern Med 151 11 (1991) 2225-2229
56. Scheffler N.M., Sheitel P.L., and Lipton M.N. Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 81 6 (1991) 288-293
57. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group. Diabetes Care 15 2 (1992) 159-165
58. Tandan R., Lewis G.A., Krusinski P.B., et al. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care 15 1 (1992) 8-14
59. Biesbroeck R., Bril V., Hollander P., et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 12 2 (1995) 111-120
60. Kennedy W.R., Navarro X., Goetz F.C., et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322 15 (1990) 1031-1037
61. Muller-Felber W., Landgraf R., Wagner S., et al. Follow-up study of sensory-motor polyneuropathy in type 1 (insulin-dependent) diabetic subjects after simultaneous pancreas and kidney transplantation and after graft rejection. Diabetologia 34 Suppl 1 (1991) S113-S117
62. Muller-Felber W., Landgraf R., Scheuer R., et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 42 10 (1993) 1482-1486
63. Allen R.D., Al-Harbi I.S., Morris J.G., et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 63 6 (1997) 830-838
64. Tyden G., Bolinder J., Solders G., et al. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 67 5 (1999) 645-648
65. Abendroth D., Schmand J., Landgraf R., et al. Diabetic microangiopathy in type 1 (insulin-dependent) diabetic patients after successful pancreatic and kidney or solitary kidney transplantation. Diabetologia 34 Suppl 1 (1991) S131-S134
66. Jukema J.W., Smets Y.F., van der Pijl J.W., et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 25 5 (2002) 906-911
67. Low P.A., Schmelzer J.D., Ward K.K., et al. Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp Neurol 99 1 (1988) 201-212
68. Smith W.J., Diemel L.T., Leach R.M., et al. Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience 45 2 (1991) 255-259
69. Hendriksen P.H., Oey P.L., Wieneke G.H., et al. Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats. J Neurol Sci 110 1-2 (1992) 99-106
70. Akbari C.M., Gibbons G.W., Habershaw G.M., et al. The effect of arterial reconstruction on the natural history of diabetic neuropathy. Arch Surg 132 2 (1997) 148-152
71. Aszmann O.C., Kress K.M., and Dellon A.L. Results of decompression of peripheral nerves in diabetics: a prospective, blinded study. Plast Reconstr Surg 106 4 (2000) 816-822
72. Wood W.A., and Wood M.A. Decompression of peripheral nerves for diabetic neuropathy in the lower extremity. J Foot Ankle Surg 42 5 (2003) 268-275
73. Rader A.J. Surgical decompression in lower-extremity diabetic peripheral neuropathy. Am Podiatr Med Assoc 95 5 (2005) 446-450
74. Valdivia J.M., Dellon A.L., Weinand M.E., et al. Surgical treatment of peripheral neuropathy: outcomes from 100 consecutive decompressions. J Am Podiatr Med Assoc 95 5 (2005) 451-454
75. Chattopadhyay M., Krisky D., Wolfe D., et al. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther 12 18 (2005) 1377-1384
76. Kusano K.F., Allendoerfer K.L., Munger W., et al. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler Thromb Vasc Biol 24 11 (2004) 2102-2107
77. Kato N., Nemoto K., Nakanishi K., et al. Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 54 3 (2005) 846-854
78. Vinik A.I., Bril V., Kempler P., et al. the MBBQ Study Group. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther 27 8 (2005) 1164-1180
79. Sindrup S.H., Graf A., and Sfikas N. The NK(1)-receptor antagonist TKA731 in painful diabetic neuropathy: a randomised, controlled trial. Eur J Pain Sep (2005) 28 [Epub]
80. Sima A.A., Calvani M., Mehra M., et al. Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28 1 (2005) 89-94
81. Clifft J.K., Kasser R.J., Newton T.S., et al. The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study. Diabetes Care 28 12 (2005) 2896-2900
82. Bosi E., Conti M., Vermigli C., et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia 48 5 (2005) 817-823
83. Daousi C., Benbow S.J., and MacFarlane I.A. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med 22 4 (2005) 393-398